Clinical Trial Update: A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers [Phase 1]

View source ↗

Summary

Phase 1 pilot trial evaluating the efficacy and safety of Ariva Silver Wintergreen in healthy smokers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Ariva Silver Wintergreen (smoking aversive lozenge)

Snippet

Sponsor: Star Scientific, Inc | Conditions: Tobacco Use Disorder, Smoking | Phase 1 | Status: COMPLETED